Capital Fund Management (CFM)
PBYI icon

Capital Fund Management (CFM)’s Puma Biotechnology PBYI Stock Holding History

Capital Fund Management (CFM)’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-36,706
Closed -$257K – 1784
2021
Q3 		$257K Buy
36,706
+1,647
+5% +$12.3K ﹤0.01% 1464
2021
Q2 		$322K Buy
35,059
+1,634
+5% +$16.6K ﹤0.01% 1351
2021
Q1 		$325K Buy
33,425
+1,109
+3% +$12.4K ﹤0.01% 1199
2020
Q4 		$332K Buy
32,316
+9,019
+39% +$91.3K ﹤0.01% 1194
2020
Q3 		$235K Buy
+23,297
New +$237K ﹤0.01% 1157
2019
Q3 		– Sell
-94,439
Closed -$1.2M – 1831
2019
Q2 		$1.2M Buy
+94,439
New +$2.17M 0.01% 963
2018
Q3 		– Sell
-10,003
Closed -$592K – 2184
2018
Q2 		$592K Sell
10,003
-14,791
-60% -$857K ﹤0.01% 1536
2018
Q1 		$1.69M Buy
+24,794
New +$1.86M 0.01% 1065
2017
Q2 		– Sell
-87,755
Closed -$3.26M – 1662
2017
Q1 		$3.26M Buy
+87,755
New +$3.2M 0.03% 599
2016
Q4 		– Sell
-8,590
Closed -$576K – 1807
2016
Q3 		$576K Buy
+8,590
New +$434K 0.01% 1157
2015
Q1 		– Sell
-2,999
Closed -$568K – 1650
2014
Q4 		$568K Buy
+2,999
New +$665K 0.01% 1080
2014
Q3 		– Sell
-25,936
Closed -$1.71M – 1750
2014
Q2 		$1.71M Buy
+25,936
New +$1.84M 0.02% 775

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Capital Fund Management (CFM)'s PBYI Position: Q4 2021 in Review

Capital Fund Management (CFM) sold out of Puma Biotechnology (PBYI) in Q4 2021, closing a stake of 36,706 shares — an estimated $257K sold.

Capital Fund Management (CFM) first reported a position in PBYI in Q2 2014 and held it in 12 quarters. The position peaked at $3.26M in Q1 2017. 102 funds tracked by Wall St. Rank hold PBYI as of Q4 2021.

  • Capital Fund Management (CFM) reported no remaining Puma Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 36,706 Puma Biotechnology shares in Q4 2021, an estimated $257K.
  • Capital Fund Management (CFM) first reported a position in Puma Biotechnology in Q2 2014 and held it in 12 quarters.
  • Capital Fund Management (CFM)'s Puma Biotechnology position peaked at $3.26M in Q1 2017.
  • 102 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2021, filed 10 Feb 2022.